SCHEMBL7495403

SCHEMBL7495403

NC(=O)N(c1ccccc1)c1cccc(C(=O)CN2CCC(Cc3ccccc3)CC2)c1

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.61
GAA P10253 1/20 0.50
GRIN2B Q13224 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7495211 0.83 F2 (0.51)
SCHEMBL10460706 0.76 ACHE (1.00) ACHEGRIN2B
SCHEMBL6701926 0.76 ACHE (0.64) ACHE
Hydrochloric Acid SCHEMBL9371874 0.75 ACHE (0.98) ACHEGRIN2B
SCHEMBL4281407 0.75 GAA (0.64) ACHEGAAGRIN2B
SCHEMBL10730073 0.73 ACHE (0.70) ACHEGAA
SCHEMBL28741673 0.73 PARP14 (0.48) ACHEGRIN2B
SCHEMBL7496134 0.73 GAA (0.41) ACHEGAA
SCHEMBL7499062 0.73 GAA (0.51) GAAGRIN2B
SCHEMBL4023997 0.72 GRIN2B (0.66) ACHEGAAGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140087-A4 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY DU PONT PHARM CO (US) 2002-04-03 EP claimed
EP-1140087-A1 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Du Pont Pharmaceuticals Company (US) 2001-10-10 EP claimed
WO-2000035454-A1 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY DU PONT PHARMACEUTICALS COMPANY (US) 2000-06-22 WO claimed
EP-1140087-A4 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY DU PONT PHARM CO (US) 2002-04-03 EP disclosed
EP-1140087-A1 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Du Pont Pharmaceuticals Company (US) 2001-10-10 EP disclosed
WO-2000035454-A1 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY DU PONT PHARMACEUTICALS COMPANY (US) 2000-06-22 WO disclosed